Prolonged STAT1 Activation Is Associated with Interferon-γ Priming for Interleukin-1-induced Inducible Nitric-oxide Synthase Expression by Islets of Langerhans*
暂无分享,去创建一个
[1] J. Corbett,et al. IL-1 produced and released endogenously within human islets inhibits beta cell function. , 1998, The Journal of clinical investigation.
[2] J. Corbett,et al. Double-stranded RNA-induced Inducible Nitric-oxide Synthase Expression and Interleukin-1 Release by Murine Macrophages Requires NF-κB Activation* , 1998, The Journal of Biological Chemistry.
[3] J. Corbett,et al. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. , 1998, Journal of immunology.
[4] C. Benoist,et al. Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Darnell. STATs and gene regulation. , 1997, Science.
[6] J. Corbett,et al. Interferon-γ Increases the Sensitivity of Islets of Langerhans for Inducible Nitric-oxide Synthase Expression Induced by Interleukin 1* , 1997, The Journal of Biological Chemistry.
[7] J. Darnell,et al. The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. , 1996, The EMBO journal.
[8] Xiaojian Huang,et al. Genetic Absence of γ-Interferon Delays but Does Not Prevent Diabetes in NOD Mice , 1996, Diabetes.
[9] M. Mcdaniel,et al. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase , 1995, The Journal of experimental medicine.
[10] M. Mcdaniel,et al. Tyrosine kinase involvement in IL-1 beta-induced expression of iNOS by beta-cells purified from islets of Langerhans. , 1994, The American journal of physiology.
[11] M. Mcdaniel,et al. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. , 1994, The Biochemical journal.
[12] E. Unanue,et al. Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[13] C. Nathan,et al. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide , 1993, The Journal of experimental medicine.
[14] M. Mcdaniel,et al. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Mcdaniel,et al. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. , 1992, The Journal of clinical investigation.
[16] B. Wolf,et al. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. , 1992, The Biochemical journal.
[17] N. Welsh,et al. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. , 1991, Endocrinology.
[18] W. Arend. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. , 1991, The Journal of clinical investigation.
[19] P. Lacy,et al. Activation of intraislet lymphoid cells causes destruction of islet cells. , 1991, The American journal of pathology.
[20] P. Bedossa,et al. Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. , 1991, Journal of autoimmunity.
[21] L. Harrison,et al. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. , 1991, The Journal of clinical investigation.
[22] I. Green,et al. Inhibition of insulin secretion by interleukin‐1β and tumour necrosis factor‐α via an L‐arginine‐dependent nitric oxide generating mechanism , 1990 .
[23] M. Mcdaniel,et al. Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. , 1990, The Journal of clinical investigation.
[24] A. Rabinovitch,et al. Interferon-gamma sensitizes rat pancreatic islet cells to lysis by cytokines and cytotoxic cells. , 1990, Journal of autoimmunity.
[25] S. Galli,et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines , 1989, The Journal of experimental medicine.
[26] N. Sarvetnick,et al. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma , 1988, Cell.
[27] D. Pipeleers,et al. A new in vitro model for the study of pancreatic A and B cells. , 1985, Endocrinology.
[28] J. Nerup,et al. Cytokines Cause Functional and Structural Damage to Isolated Islets of Langerhans , 1985, Allergy.
[29] P. Lacy,et al. A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans. , 1983, Methods in enzymology.
[30] S. Tannenbaum,et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.
[31] J. Ono,et al. Preparation of single cells from pancreatic islets of adult rat by the use of dispase. , 1977, Endocrinologia japonica.
[32] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.